{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:12:59Z","timestamp":1788261179845,"version":"build-2803163510"},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1001\/jamainternmed.2018.3504","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T16:31:56Z","timestamp":1532968316000},"page":"1153","source":"Crossref","is-referenced-by-count":35,"title":["Implementing Opioid Agonist Treatment in Correctional Facilities"],"prefix":"10.1001","volume":"178","author":[{"given":"Kevin","family":"Fiscella","sequence":"first","affiliation":[{"name":"Department of Family Medicine, University of Rochester Medical Center, Rochester, New York"},{"name":"Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Wakeman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Beletsky","sequence":"additional","affiliation":[{"name":"School of Law, Northeastern University, Boston, Massachusetts"},{"name":"Bouv\u00e9 College of Health Sciences, Northeastern University, Boston, Massachusetts"},{"name":"Division of Global Public Health and Infectious Diseases, Department of Medicine, University of California, San Diego School of Medicine, LaJolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ivp180016r1","first-page":"27","article-title":"Pharmacotherapy for opioid dependence in jails and prisons.","volume":"7","author":"Sharma","year":"2016","journal-title":"Subst Abuse Rehabil"},{"key":"ivp180016r2","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"ivp180016r3","first-page":"155","article-title":"Fatal re-entry: legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceration.","volume":"7","author":"Beletsky","year":"2015","journal-title":"Northeastern Univ Law J"},{"issue":"9991","key":"ivp180016r4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail.","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"ivp180016r5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/add.2010.105.issue-9","article-title":"Meta-analysis of drug-related deaths soon after release from prison.","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"ivp180016r6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system.","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ivp180016r7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ADM.0000000000000381","article-title":"Feasibility and effectiveness of continuing methadone maintenance treatment during incarceration compared with forced withdrawal.","volume":"12","author":"Moore","year":"2018","journal-title":"J Addict Med"},{"issue":"9","key":"ivp180016r8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/journalofethics.2017.19.9.stas1-1709","article-title":"Why it\u2019s inappropriate not to treat incarcerated patients with opioid agonist therapy.","volume":"19","author":"Wakeman","year":"2017","journal-title":"AMA J Ethics"},{"key":"ivp180016r9","unstructured":"FreyerFJ. US investigating treatment of addicted prisoners in Mass. Boston Globe. Published March 28, 2018.https:\/\/www.bostonglobe.com\/metro\/2018\/03\/28\/investigating-treatment-addicted-prisoners-mass\/XUDpQI8tdOhB1QPUPljJyM\/story.html. Accessed May 31, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2687993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:34:12Z","timestamp":1536064452000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2018.3504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2018.3504","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}